These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2500481)
1. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. Ksander BR; Streilein JW J Immunol; 1989 Jul; 143(2):426-31. PubMed ID: 2500481 [TBL] [Abstract][Full Text] [Related]
2. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes. Miki S; Ksander B; Streilein JW Reg Immunol; 1992; 4(6):352-62. PubMed ID: 1297406 [TBL] [Abstract][Full Text] [Related]
3. Infiltration and accumulation of precursor cytotoxic T-cells increase with time in progressively growing ocular tumors. Ksander BR; Bando Y; Acevedo J; Streilein JW Cancer Res; 1991 Jun; 51(12):3153-8. PubMed ID: 1904003 [TBL] [Abstract][Full Text] [Related]
4. Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites. Ksander BR; Streilein JW J Immunol; 1990 Oct; 145(7):2057-63. PubMed ID: 1975822 [TBL] [Abstract][Full Text] [Related]
5. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
6. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors. Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486 [TBL] [Abstract][Full Text] [Related]
7. Growth of P511 mastocytoma cells in BALB/c mouse brain elicits CTL response without tumor elimination: a new tumor model for regional central nervous system immunity. Gordon LB; Nolan SC; Cserr HF; Knopf PM; Harling-Berg CJ J Immunol; 1997 Sep; 159(5):2399-408. PubMed ID: 9278331 [TBL] [Abstract][Full Text] [Related]
8. Termination of immune privilege in the anterior chamber of the eye when tumor-infiltrating lymphocytes acquire cytolytic function. Ksander BR; Mammolenti MM; Streilein JW Transplantation; 1991 Jul; 52(1):128-33. PubMed ID: 1907041 [TBL] [Abstract][Full Text] [Related]
9. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. 1989. Ksander BR; Streilein JW Ocul Immunol Inflamm; 2007; 15(3):205-13. PubMed ID: 17613835 [No Abstract] [Full Text] [Related]
10. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Yamada J; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871 [TBL] [Abstract][Full Text] [Related]
12. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo. Nevala WK; Paul C; Wettstein PJ J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948 [TBL] [Abstract][Full Text] [Related]
13. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors. Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785 [TBL] [Abstract][Full Text] [Related]
14. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells. Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701 [TBL] [Abstract][Full Text] [Related]
15. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses. Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051 [TBL] [Abstract][Full Text] [Related]
16. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies. Carayanniotis G; Halloran PF Cell Immunol; 1985 Mar; 91(1):100-10. PubMed ID: 2857596 [TBL] [Abstract][Full Text] [Related]
17. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658 [TBL] [Abstract][Full Text] [Related]
18. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells. Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791 [TBL] [Abstract][Full Text] [Related]
19. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2. Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360 [TBL] [Abstract][Full Text] [Related]
20. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape. Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]